CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Operating activities:
Net income	$ 92,138	$ 481,447
Adjustments to reconcile net income to net cash provided from operating activities:
Deferred income tax expense	16,622	119,180
Depletion, depreciation and amortization	87,137	86,562
Abandonment and impairment of unproved properties	2,371	7,510
Derivative fair value income	(46,598)	(367,967)
Cash settlements on derivative financial instruments	122,373	34,468
Divestiture contract obligation, including accretion	10,267	12,215
Amortization of deferred financing costs and other	1,232	1,310
Deferred and stock-based compensation	18,215	20,681
Gain on the sale of assets	(87)	(138)
Gain on early extinguishment of debt	(64)	0
Changes in working capital:
Accounts receivable	107,454	225,213
Other current assets	(8,944)	(5,335)
Accounts payable	12,188	(10,822)
Accrued liabilities and other	(82,374)	(129,368)
Net cash provided from operating activities	331,930	474,956
Investing activities:
Additions to natural gas properties	(132,881)	(125,468)
Additions to field service assets	(1,003)	(74)
Acreage purchases	(21,714)	(12,742)
Proceeds from disposal of assets	31	660
Purchases of marketable securities held by the deferred compensation plan	(13,556)	(1,869)
Proceeds from the sales of marketable securities held by the deferred compensation plan	15,234	1,200
Net cash used in investing activities	(153,889)	(138,293)
Financing activities:
Borrowings on credit facility	0	185,000
Repayments on credit facility	0	(204,000)
Repayment of senior notes	(14,975)	0
Dividends paid	(19,407)	(19,334)
Treasury stock purchases	0	(7,834)
Taxes paid for shares withheld	(24,214)	(39,057)
Change in cash overdrafts	10,003	(29,064)
Proceeds from the sales of common stock held by the deferred compensation plan	1,689	5,052
Net cash used in financing activities	(46,904)	(109,237)
Increase in cash and cash equivalents	131,137	227,426
Cash and cash equivalents at beginning of period	211,974	207
Cash and cash equivalents at end of period	$ 343,111	$ 227,633